BREAST CANCER DIAGNOSIS USING NIPPLE DISCHARGE
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Feb 6, 2014
app pub date -
Jan 26, 2012
filing date -
Feb 10, 2011
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A panel of biomarkers for the prediction of breast cancer using nipple discharge, as well as method and kits for using the same. Nipple discharge may be nipple aspirate fluid or spontaneous discharge. The panel has been selected to optimize predictive ability while minimizing the number of markers to be screened. As observed, the panel approaches one hundred percent accuracy for predicting breast cancer without the need for invasive biopsy.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully